The results of the current study are concordant with recent in vivo studies in which propofol suppressed inflammatory cytokine production via inhibition of TLR4-dependent pathways in various disease models, including lung [12], liver [13], and gastric injuries [14], and asthma [28]. The gene discussed is TLR4; the disease is asthma.